Intended for healthcare professionals

Feature Conflicts of Interest

US opioid prescribing: the federal government advisers with recent ties to big pharma

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5167 (Published 22 August 2019) Cite this as: BMJ 2019;366:l5167

Linked news

Opioid policies: scientists advising US government had commercial ties, BMJ investigation finds

NewsOpioid policies: scientists advising US government had commercial ties, BMJ investigation finds

Cited by...

Opioid policies: scientists advising US government had commercial ties, BMJ investigation finds
- Fulltext
- PDF

Article tools

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

Tim Schwab independent journalist, Washington, DC, and 2019 Alicia Patterson Foundation fellow

Schwab T. US opioid prescribing: the federal government advisers with recent ties to big pharma BMJ 2019; 366 :l5167 doi:10.1136/bmj.l5167

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions